Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia

Clinical trial NCT02155881 · COMPLETED

Trial details

NCT number: NCT02155881
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2014-08-01
Primary completion: 2014-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.